Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine) - Image 1

£125.00

Woodhead Publishing Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)

Name: Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)
Brand: Woodhead Publishing
Price: 128.48 GBP
Availability: InStock

Allied Health Professions

Price History & Forecast

Last 81 days • 81 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £128 (65 days, 80.2%)

Price range: £125 - £128

Price levels: 2 different prices over 81 days

Description

This authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 and 7,000 rare diseases and the number of patients suffering from them is estimated to be more than 50 million in the US and Europe. Before the orphan drug legislation enacted in the US in 1983, there was a limited interest from industry to develop treatment for very small patient groups. One of the difficulties is, of course, that similar levels of investment are needed from a pharmaceutical company to bring a drug to the market for both small and large patient groups.The journey from application of an orphan drug designation to a reimbursed market- approved drug is long and many obstacles occur during the journey.After reading the book, readers will: Understand who the players/stakeholders are in the rare orphan disease field and their specific needs and concerns: patients and patient organizations, researchers and treating physicians within the field, industry, regulatory and reimbursement bodies* Understand the strong partnership between the different players and the various initiatives to improve and increase access to treatment for patients; minimizing the gap between numbers of known diseases, orphan designations, approved drugs and paid drugs.The book also provides short practical case stories from patients and researchers, as well as representatives from industry and authorities on the challenges they came across in developing orphan drugs or getting access to orphan drugs. A comprehensive overview of strategy, key activities and considerations of how to bring an orphan drug from concept to the market and make it available to patients A source of updated information, news and trends for those who are already active in this fast-evolving field Covers the global definitions and the criteria for getting an orphan drug designation in, for example, the US and Europe

Product Specifications

Brand: Woodhead Publishing
Format: hardcover
ASIN: 1907568093
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions
Domain: Amazon UK
Release Date: 31 January 2014
Listed Since: 30 June 2011

Barcode

No barcode data available

Woodhead Publishing Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics (Woodhead Publishing Series in Biomedicine)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Drug Development & Rare Pediatric Diseases: Issues, Strategic Plan, & Voucher Program Assessment (Pharmacology-research, Safety Testing and Regulation)

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey (AIPPI Law, 7)

Global Issues in Pharmaceutical Marketing

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

Fundamentals of Early Clinical Drug Development: From Synthesis Design to Formulation

Chemistry and Molecular Aspects of Drug Design and Action

Drug Information: A Guide for Pharmacists, Fourth Edition

Pediatric Pharmacotherapy: 261 (Handbook of Experimental Pharmacology, 261)

Angewandte klinische Pharmakologie: Phase-I-Prüfungen: 214 (Heidelberger Taschenbücher, 214)

Drug Control and International Law (Routledge Research in International Law)

Rare Diseases: Challenges and Opportunities for Social Entrepreneurs

Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries

Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact

Encyclopedia of Traditional Chinese Medicines - Molecular Structures, Pharmacological Activities, Natural Sources and Applications: Vol. 4: Isolated Compounds N-S

Drug Discovery in Africa: Impacts of Genomics, Natural Products, Traditional Medicines, Insights into Medicinal Chemistry, and Technology Platforms in Pursuit of New Drugs

Fundamentals of Medicinal Chemistry

Molecular Therapeutics: 21st Century Medicine

The 2007 Import and Export Market for Penicillins and Derivatives with a Penicillanic Acid Structure and Salts Thereof in United States

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

The Science and Business of Drug Discovery: Demystifying the Jargon

The Public Financing of Pharmaceuticals: An Economic Approach